| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.77B | 30.64B | 31.83B | 34.36B | 45.45B | 37.78B |
| Gross Profit | 14.04B | 11.28B | 15.19B | 14.25B | 20.98B | 10.18B |
| EBITDA | 8.75B | 6.89B | 8.76B | 11.20B | 15.95B | 7.32B |
| Net Income | 5.70B | 4.72B | 6.24B | 7.94B | 11.42B | 6.50B |
Balance Sheet | ||||||
| Total Assets | 42.72B | 43.00B | 41.85B | 37.70B | 51.33B | 49.95B |
| Cash, Cash Equivalents and Short-Term Investments | 11.23B | 11.18B | 10.74B | 8.93B | 5.00B | 2.44B |
| Total Debt | 968.20M | 833.00M | 1.19B | 2.10B | 3.61B | 7.88B |
| Total Liabilities | 6.36B | 7.48B | 6.97B | 7.91B | 11.78B | 19.10B |
| Stockholders Equity | 36.36B | 35.52B | 34.89B | 29.78B | 39.56B | 29.47B |
Cash Flow | ||||||
| Free Cash Flow | 1.38B | 4.40B | 3.23B | 6.91B | 4.99B | 3.06B |
| Operating Cash Flow | 3.23B | 7.04B | 6.38B | 7.97B | 8.56B | 6.43B |
| Investing Cash Flow | -2.35B | -3.15B | -3.58B | -5.34B | -4.03B | -3.37B |
| Financing Cash Flow | -1.30B | -4.44B | -2.30B | -3.38B | -5.36B | -980.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ₹76.22B | 6.67 | ― | 3.68% | -1.51% | 35.32% | |
75 Outperform | ₹41.35B | 8.43 | ― | 2.10% | -3.75% | -23.83% | |
72 Outperform | ₹78.25B | 15.33 | ― | 1.05% | -2.51% | -11.80% | |
66 Neutral | ₹57.17B | 18.92 | ― | 0.97% | 2.00% | 7.14% | |
65 Neutral | ₹50.19B | -46.40 | ― | 3.11% | 7.73% | 92.87% | |
62 Neutral | ₹67.38B | 11.49 | ― | 2.80% | 6.87% | 27.25% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |